AI Diabetic Retinopathy Screening in a Primary Care Setting in Rural Maine

Rachel Heuer MD
Emma DayBranch MPH, Center for Interdisciplinary Population and Health Research, MaineHealth Institute for Research, Portland, ME.
Anastasia Tsomides DO, University of New England College of Osteopathic Medicine
Jessica F. DiBiase MPH, Center for Interdisciplinary Population and Health Research, MaineHealth Institute for Research, Portland, ME.
Neil Korsen MD, Center for Interdisciplinary Population and Health Research, MaineHealth Institute for Research, Portland, ME.
Brian M. Nolan MD, MaineHealth

Collaboration with REACH: Research Evidence-to-Action for Community Health

This work was supported by the National Institutes of Health [U54 GM115516] for the Northern New England Clinical and Translational Research Network

Description

Diabetic retinopathy (DR) is the leading cause of blindness globally. Early diagnosis and treatment reduce the risk of vision loss by 98%.